8-K/A

AMENDED CURRENT REPORT

Company: Actinium Pharmaceuticals, Inc.
Filed: January 4, 2013
Period of Report: December 28, 2012
Accession Number: 0001213900-13-000029

View Document ↗ View on SEC.gov ↗